Cresco Labs Inc.
Cresco Labs Inc. (CRLBF) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
crlbf · stock forecast · 7 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 7 Wall Street analysts in the past 3 months
Buy
7 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$8.50
Consensus
$5.50
+479.1% upside
Low
$2.50
Median: $5.5 · Last Close: $0.95
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$5.50
479.1% upside
High Target
$8.5
795.0%
Low Target
$2.5
163.2%
Current Price
$0.95
as of today
Based on analyst price targets, the CRLBF stock price prediction for the next 12 months ranges from $2.5 to $8.5. The consensus CRLBF price forecast of $5.50 implies 479.1% upside from the current price of $0.95.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.95 | ↓ 0.27% |
1-day model range: $0.94–$0.96. Peak: $0.96 (-0.27%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CRLBF · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-05-16 | Needham | Maintains | Hold→Hold |
| 2024-05-16 | Wedbush | Maintains | Outperform→Outperform |
| 2024-03-14 | Roth MKM | Maintains | Neutral→Neutral |
| 2023-03-20 | Wedbush | Maintains | Outperform→Outperform |
| 2023-02-24 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2022-12-30 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2022-12-20 | Cowen & Co. | Downgrade ↓ | Outperform→Market Perform |
| 2022-12-02 | Wedbush | Maintains | Outperform→Outperform |
| 2022-08-18 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2022-08-18 | Piper Sandler | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Cresco Labs Inc. (CRLBF) stock. Of the recent 23 rating actions, 0 were upgrades and 1 were downgrades. 7 analysts currently cover CRLBF.
Analyst Recommendation Trends
CRLBF analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$653M
↓ 3.3% YoY
Revenue Next Year
$677M
↑ 3.6% YoY
EPS This Year
$-0.08
EPS Next Year
$-0.01
↓ 92.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast CRLBF EPS of $-0.08 for the current fiscal year, based on estimates from 2 analysts. The CRLBF revenue forecast is $653M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CRLBF stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CRLBF price target is $5.50 (+479.1% upside), with an analyst consensus of Buy.
The CRLBF short-term stock prediction for tomorrow is $0.95 (-0.27%).
Cresco Labs Inc. trades on OTC under the ticker CRLBF. The CRLBF stock outlook for 2027 is broadly positive, supported by a Buy consensus among 57% of covering analysts.
Frequently asked questions
CRLBF forecast · 8 questionsAccording to 7 Wall Street analysts, the average 12-month CRLBF price target is $5.50, with a high forecast of $8.50 and a low of $2.50. The median price target is shown in the chart above when available. This implies +479.1% potential upside from the current price of $0.95.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.